Collectively, these results suggest that the antiviral response of IRF1-deficient cells to IFN-α and IFN-γ is only mildly impaired and sufficient to protect IRF1-deficient fibroblasts against viral infection, consistent with the absence of severe viral illnesses in these two patients. The gene discussed is IFNA2; the disease is viral infectious disease.